Turtle Cameron bought ORKA
June 2, 2025 · Form 4 insider transaction
Turtle Cameron bought 17,500 shares of Oruka Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
17,500
Price
$0.00
Total value
N/A
InsiderTurtle Cameron
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 2, 2025
Filing dateJune 3, 2025
Shares owned after17,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests as to 1/12 of the underlying shares monthly from June 2, 2025.